60 related articles for article (PubMed ID: 10874382)
21. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects.
Ray GT; Whitney CG; Fireman BH; Ciuryla V; Black SB
Pediatr Infect Dis J; 2006 Jun; 25(6):494-501. PubMed ID: 16732146
[TBL] [Abstract][Full Text] [Related]
23. [Cost-effectiveness of pneumococcal vaccination of the elderly].
Hak E; Grobbee DE; Verheij TJ
Ned Tijdschr Geneeskd; 1998 Jan; 142(4):201-2; author reply 202-3. PubMed ID: 9557028
[No Abstract] [Full Text] [Related]
24. [Cost-effectiveness of pneumococcal vaccination in the elderly].
van den Berg JW
Ned Tijdschr Geneeskd; 1998 Jan; 142(4):202-3. PubMed ID: 9557029
[No Abstract] [Full Text] [Related]
25. The basics of decision analysis.
Kent DL
J Dent Educ; 1992 Dec; 56(12):791-9. PubMed ID: 1487581
[TBL] [Abstract][Full Text] [Related]
26. Pneumococcal vaccination: four issues for western Europe.
Fedson DS
Biologicals; 1997 Jun; 25(2):215-9. PubMed ID: 9236055
[No Abstract] [Full Text] [Related]
27. Uncertainty and sensitivity analyses of a dynamic economic evaluation model for vaccination programs.
Duintjer Tebbens RJ; Thompson KM; Hunink MG; Mazzuchi TA; Lewandowski D; Kurowicka D; Cooke RM
Med Decis Making; 2008; 28(2):182-200. PubMed ID: 18349438
[TBL] [Abstract][Full Text] [Related]
28. Do Quality-Adjusted Life Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness Analyses.
Xie F; Zhou T; Humphries B; Neumann PJ
Value Health; 2024 Jun; 27(6):706-712. PubMed ID: 38548176
[TBL] [Abstract][Full Text] [Related]
29. An algorithm to generate correlated input-parameters to be used in probabilistic sensitivity analyses.
Neine M; Curran D
J Mark Access Health Policy; 2020 Dec; 9(1):1857052. PubMed ID: 33403091
[No Abstract] [Full Text] [Related]
30. Some Health States Are Better Than Others: Using Health State Rank Order to Improve Probabilistic Analyses.
Goldhaber-Fiebert JD; Jalal HJ
Med Decis Making; 2016 Nov; 36(8):927-40. PubMed ID: 26377369
[TBL] [Abstract][Full Text] [Related]
31. One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit.
McCabe C; Paulden M; Awotwe I; Sutton A; Hall P
Pharmacoeconomics; 2020 Feb; 38(2):135-141. PubMed ID: 31840216
[TBL] [Abstract][Full Text] [Related]
32. The Application and Implications of Novel Deterministic Sensitivity Analysis Methods.
Vreman RA; Geenen JW; Knies S; Mantel-Teeuwisse AK; Leufkens HGM; Goettsch WG
Pharmacoeconomics; 2021 Jan; 39(1):1-17. PubMed ID: 33313990
[TBL] [Abstract][Full Text] [Related]
33. Multivariable and Structural Uncertainty Analyses for Cost-Effectiveness Estimates: Back to the Future.
Mauskopf J
Value Health; 2019 May; 22(5):570-574. PubMed ID: 31104736
[TBL] [Abstract][Full Text] [Related]
34. Probabilistic measures of cost-effectiveness.
Bebu I; Mathew T; Lachin JM
Stat Med; 2016 Sep; 35(22):3976-86. PubMed ID: 27194076
[TBL] [Abstract][Full Text] [Related]
35. Understanding bias in probabilistic analysis in model-based health economic evaluation.
Xie X; Schaink AK; Liu S; Wang M; Volodin A
Eur J Health Econ; 2023 Mar; 24(2):307-319. PubMed ID: 35610397
[TBL] [Abstract][Full Text] [Related]
36. Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier.
McCabe C; Tramonti G; Sutton A; Hall P; Paulden M
Pharmacoeconomics; 2021 Jan; 39(1):19-24. PubMed ID: 33225423
[TBL] [Abstract][Full Text] [Related]
37. A regression framework for a probabilistic measure of cost-effectiveness.
Illenberger N; Mitra N; Spieker AJ
Health Econ; 2022 Jul; 31(7):1438-1451. PubMed ID: 35460149
[TBL] [Abstract][Full Text] [Related]
38. The CE plane: a graphic representation of cost-effectiveness.
Black WC
Med Decis Making; 1990; 10(3):212-4. PubMed ID: 2115096
[TBL] [Abstract][Full Text] [Related]
39. Increasing the information provided by probabilistic sensitivity analysis: The relative density plot.
Geenen JW; Vreman RA; Boersma C; Klungel OH; Hövels AM; Ham RMTT
Cost Eff Resour Alloc; 2020 Nov; 18(1):54. PubMed ID: 33292291
[TBL] [Abstract][Full Text] [Related]
40. The Case for Vaccination.-From a Pathological Standpoint.
Copeman SM
Hospital (Lond 1886); 1895 Dec; 19(481):181-182. PubMed ID: 29835777
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
